Thalia Therapeutics PLC (THAT)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.55p
Buy
0.60p
0.00p (+0.00%)
Prices updated at 09 Jun 2026, 11:51 BST
| Prices minimum 15 mins delay
Prices in GBX
Thalia Therapeutics PLC is a biotechnology company developing RNA-based therapeutics and delivery technologies in oncology and cardiovascular disease. Its pipeline includes a long-duration, dual-acting siRNA program targeting PCSK9 and lipoprotein(a) ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
09 Jun 202602 Jun 202613 May 202617 Mar 202627 Feb 202624 Feb 202617 Dec 202525 Sep 202523 Sep 202522 Sep 2025
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Sep 2026 |
| Annual general meeting | Jun 2026 |
| Annual report | Jun 2026 |
| Final results | Jun 2026 |
| Previous date | |
|---|---|
| Half yearly results | Sep 2025 |
| Annual general meeting | Jun 2025 |
| Final results | Jun 2025 |
| Annual report | Jun 2025 |
Company reports
31 Dec 2022
Annual Report 30 Jun 2025
Quarterly Report 